Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 02 Jan 2026 for Janux Therapeutics, Inc., €28k. Read the official filing
Filing timeline
BuySaleCharles M. Winter
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Charles M. Winter: trading record in brief
Charles M. Winter discloses dealings in Janux Therapeutics, Inc. to SEC (Form 4). Between 2 January 2025 and 2 January 2026, the trades on record add up to 2 filings.
Sales make up the whole of the open-market record (1 sale, €28k). Besides market trades, the filings include 1 share grant. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 2 January 2026, the filings show an open-market sale worth €28k in Janux Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles M. Winter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,401 shares@ US$13.73Common StockSEC:0001960264-26-000002:0
23,000 shares0Common StockSEC:0001415889-25-000676:0
2 of 2 declarations
